Defects in lipid homeostasis reflect the function of TANGO2 in phospholipid and neutral lipid metabolism

  1. Agustin Leonardo Lujan
  2. Ombretta Foresti
  3. Conor Sugden
  4. Nathalie Brouwers
  5. Alex Mateo Farre
  6. Alessio Vignoli
  7. Mahshid Azamian
  8. Alicia Turner
  9. Jose Wojnacki
  10. Vivek Malhotra  Is a corresponding author
  1. Barcelona Institute for Science and Technology, Spain
  2. Baylor College of Medicine, United States

Abstract

We show that TANGO2 in mammalian cells localizes predominantly to mitochondria and partially at mitochondria sites juxtaposed to lipid droplets (LDs) and the endoplasmic reticulum. HepG2 cells and fibroblasts of patients lacking TANGO2 exhibit enlarged LDs. Quantitative lipidomics revealed a marked increase in lysophosphatidic acid (LPA) and a concomitant decrease in its biosynthetic precursor phosphatidic acid (PA). These changes were exacerbated in nutrient-starved cells. Based on our data, we suggest that TANGO2 function is linked to acyl-CoA metabolism, which is necessary for the acylation of LPA to generate PA. The defect in acyl-CoA availability impacts the metabolism of many other fatty acids, generates high levels of reactive oxygen (ROS), and promotes lipid peroxidation. We suggest that the increased size of LDs is a combination of enrichment in peroxidized lipids and a defect in their catabolism. Our findings help explain the physiological consequence of mutations in TANGO2 that induce acute metabolic crises, including rhabdomyolysis, cardiomyopathy, and cardiac arrhythmias, often leading to fatality upon starvation and stress.

Data availability

"TANGO2 - Source data files" (https://doi.org/10.5061/dryad.rn8pk0pg5) to Dryad.

The following data sets were generated
    1. Lujan AL
    (2023) TANGO2 - Source data files
    Dryad Digital Repository, doi:10.5061/dryad.rn8pk0pg5.

Article and author information

Author details

  1. Agustin Leonardo Lujan

    Centre for Genomic Regulation, Barcelona Institute for Science and Technology, Barcelona, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4906-6951
  2. Ombretta Foresti

    Centre for Genomic Regulation, Barcelona Institute for Science and Technology, Barcelona, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6878-0395
  3. Conor Sugden

    Centre for Genomic Regulation, Barcelona Institute for Science and Technology, Barcelona, Spain
    Competing interests
    No competing interests declared.
  4. Nathalie Brouwers

    Centre for Genomic Regulation, Barcelona Institute for Science and Technology, Barcelona, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9808-9394
  5. Alex Mateo Farre

    Centre for Genomic Regulation, Barcelona Institute for Science and Technology, Barcelona, Spain
    Competing interests
    No competing interests declared.
  6. Alessio Vignoli

    Centre for Genomic Regulation, Barcelona Institute for Science and Technology, Barcelona, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7131-2915
  7. Mahshid Azamian

    Center for Cell and Gene Therapy, Baylor College of Medicine, Texas, United States
    Competing interests
    No competing interests declared.
  8. Alicia Turner

    Department of Molecular and Human Genetics, Baylor College of Medicine, Texas, United States
    Competing interests
    No competing interests declared.
  9. Jose Wojnacki

    Centre for Genomic Regulation, Barcelona Institute for Science and Technology, Barcelona, Spain
    Competing interests
    No competing interests declared.
  10. Vivek Malhotra

    Centre for Genomic Regulation, Barcelona Institute for Science and Technology, Barcelona, Spain
    For correspondence
    vivek.malhotra@crg.eu
    Competing interests
    Vivek Malhotra, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6198-7943

Funding

Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (PID2019-105518GB-I00)

  • Agustin Leonardo Lujan

European Research Council (ERC-2020-SyG-Proposal No. 951146)

  • Agustin Leonardo Lujan
  • Ombretta Foresti
  • Conor Sugden
  • Nathalie Brouwers
  • Alex Mateo Farre
  • Alessio Vignoli
  • Jose Wojnacki
  • Vivek Malhotra

European Molecular Biology Organization (EMBO ALTF 659-2021)

  • Agustin Leonardo Lujan

European Research Council (H2020-MSCA-IF-2019-894115)

  • Jose Wojnacki

Ministerio de Ciencia e Innovación (RYC-2016-20919)

  • Ombretta Foresti

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Lujan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,371
    views
  • 290
    downloads
  • 12
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Agustin Leonardo Lujan
  2. Ombretta Foresti
  3. Conor Sugden
  4. Nathalie Brouwers
  5. Alex Mateo Farre
  6. Alessio Vignoli
  7. Mahshid Azamian
  8. Alicia Turner
  9. Jose Wojnacki
  10. Vivek Malhotra
(2023)
Defects in lipid homeostasis reflect the function of TANGO2 in phospholipid and neutral lipid metabolism
eLife 12:e85345.
https://doi.org/10.7554/eLife.85345

Share this article

https://doi.org/10.7554/eLife.85345

Further reading

    1. Cell Biology
    Joan Chang, Adam Pickard ... Karl E Kadler
    Research Article

    Collagen-I fibrillogenesis is crucial to health and development, where dysregulation is a hallmark of fibroproliferative diseases. Here, we show that collagen-I fibril assembly required a functional endocytic system that recycles collagen-I to assemble new fibrils. Endogenous collagen production was not required for fibrillogenesis if exogenous collagen was available, but the circadian-regulated vacuolar protein sorting (VPS) 33b and collagen-binding integrin α11 subunit were crucial to fibrillogenesis. Cells lacking VPS33B secrete soluble collagen-I protomers but were deficient in fibril formation, thus secretion and assembly are separately controlled. Overexpression of VPS33B led to loss of fibril rhythmicity and overabundance of fibrils, which was mediated through integrin α11β1. Endocytic recycling of collagen-I was enhanced in human fibroblasts isolated from idiopathic pulmonary fibrosis, where VPS33B and integrin α11 subunit were overexpressed at the fibrogenic front; this correlation between VPS33B, integrin α11 subunit, and abnormal collagen deposition was also observed in samples from patients with chronic skin wounds. In conclusion, our study showed that circadian-regulated endocytic recycling is central to homeostatic assembly of collagen fibrils and is disrupted in diseases.

    1. Cell Biology
    Chun-Wei Chen, Jeffery B Chavez ... Bruce J Nicholson
    Research Article Updated

    Endometriosis is a debilitating disease affecting 190 million women worldwide and the greatest single contributor to infertility. The most broadly accepted etiology is that uterine endometrial cells retrogradely enter the peritoneum during menses, and implant and form invasive lesions in a process analogous to cancer metastasis. However, over 90% of women suffer retrograde menstruation, but only 10% develop endometriosis, and debate continues as to whether the underlying defect is endometrial or peritoneal. Processes implicated in invasion include: enhanced motility; adhesion to, and formation of gap junctions with, the target tissue. Endometrial stromal (ESCs) from 22 endometriosis patients at different disease stages show much greater invasiveness across mesothelial (or endothelial) monolayers than ESCs from 22 control subjects, which is further enhanced by the presence of EECs. This is due to the enhanced responsiveness of endometriosis ESCs to the mesothelium, which induces migration and gap junction coupling. ESC-PMC gap junction coupling is shown to be required for invasion, while coupling between PMCs enhances mesothelial barrier breakdown.